STAT Plus: The good, the bad, and the really, really ugly behind Sarepta’s drug approval
What does it all mean now that the Food and Drug Administration has issued a…
Author: STAT
STAT Plus: U.S. Patent Office removes lawyer from high-profile case involving a Gilead HIV medicine
The U.S. Patent and Trademark Office has removed a senior legal adviser from a high-profile…
.jpg)
Opinion: Integrated care opens new doors to mental health, addiction care
In every American community — wealthy or poor, rural or urban, young or old —…
Opinion: BMJ should retract flawed research paper on chronic fatigue syndrome
Few journals have been more admirable than The BMJ (formerly the British Medical Journal) and…
My baby needed expensive intensive care, but my insurer was taking a long weekend. How can this be?
On Thanksgiving evening my baby spiked a high fever. By Friday morning her little head…
STAT Plus: Biotech veteran Chris Garabedian on Sarepta’s legacy and Biogen’s future at the FDA
This September marked the third anniversary of a pivotal moment in biotech. Back in 2016,…
FDA changes course on Sarepta’s once-rejected muscular dystrophy drug
The Food and Drug Administration reversed its decision on a treatment for Duchenne muscular dystrophy…
Opinion: Congress: Don’t eliminate funding for the diversity creating Health Career Opportunity Program
The Senate is preparing to make a big mistake with a small budget item. On…
Opinion: Machine learning for clinical decision-making: pay attention to what you don’t see
Even as machine learning and artificial intelligence are drawing substantial attention in health care, overzealousness…
Surgeons test-drive the amputation of the future with a mail-order limb, rerouted nerve, and prosthetic hand that grips like the real thing
WALTHAM, Mass. — The surgeons, peering through loupes with 3x magnification, have dissected away the…
STAT Plus: Something Ventured: Akrevia Therapeutics and three other startups got venture funding a year ago. Did it help them do what they said it would?
This story is part of STAT’s quarterly series Something Ventured, which looks at early-stage startups….
Opinion: More Americans are dying at home. Is that a good thing?
How Americans die has fundamentally changed with advances in medical technology and the ways diseases…
.jpg)
STAT Plus: After Ice Bucket campaign, researchers have optimism about insights into ALS puzzle
Five years after Pete Frates helped launch the Ice Bucket Challenge to raise awareness and…
It’s a bonanza: With drug pricing bill up for a vote, D.C. news outlets are drowning in advocacy ads
WASHINGTON — Pick up this morning’s print edition of Politico and you’ll be hard-pressed to…
Opinion: Oral immunotherapy can be a game changer for many with food allergies
Food allergies upend lives. In children, food allergies can scale back or completely stop participation…
Democrats’ drug pricing bill is a sneak peek at the party’s 2020 campaign message
WASHINGTON — If Democrats are spoiling for a 2020 fight focused on anything besides impeaching…
‘Dump it down the drain’: How contaminants from prescription-drug factories pollute waterways
A cacophony of machines, some as big as a dump truck, mix pharmaceutical ingredients, press…
Opinion: 11-country survey of primary care physicians shows where U.S. is lagging and keeping pace
Primary care is the backbone of any high-performing health care system. It works best when…
STAT Plus: In tight Massachusetts job market, it’s relo for biotech and remote for tech hires
A state unemployment rate of 2.9% doesn’t quite capture how tight the job market is…
STAT Plus: With new trade deal, Trump deals a blow to drug makers
WASHINGTON — The Trump administration’s Tuesday agreement on a new trade deal with Canada and…
STAT Plus: GAO finds ongoing problems with FDA inspections of foreign drug facilities
Amid rising concern over the quality of the pharmaceutical supply chain, a government report finds…
Opinion: I thought patriarchy in science was fading. Then I saw it in the data
As I returned home from this year’s Women in Statistics and Data Science Conference, one…
Opinion: Do large pharma companies provide drug development innovation? Our analysis says no
Large pharmaceutical companies oppose legislation being considered by Congress to lower the prices of prescription…
STAT Plus: Watch: Dr. James Wilson, a scientific pioneer, on the future of gene therapy
Dr. James Wilson is a pioneer in gene therapy. That does not mean he is…
Research using brains-in-a-dish forces a radical rethinking of Huntington’s disease
Even allowing for the fact that these were lilliputian brains, they were not behaving at…
Sanofi says Dupixent could be a $10 billion drug, aims to sell Cialis and Tamiflu over the counter
The new CEO of Sanofi, the French drug giant, believes that its drug Dupixent, for…
STAT Plus: Bristol-Myers CMO on cell therapies: ‘This is the best time to be in drug development’
ORLANDO, Fla. — In June, Dr. Samit Hirawat was appointed chief medical officer of Bristol-Myers…
Opinion: H.R. 3 is the wrong path to lower drug costs
Americans want health care to be less expensive. We also want our health care to…
STAT Plus: House Republicans fuel Capitol Hill chaos with competing drug pricing bill
WASHINGTON — Republicans on Monday are set to accelerate Capitol Hill’s drug pricing chaos with…
Opinion: The EPA’s proposed ‘transparency rule’ will harm health, safety, and the environment
A proposed rule by the Environmental Protection Agency (EPA) that allegedly aims to strengthen transparency…
‘You keep loving each other’: A window into dementia at the end of a lifelong partnership
Poul and Else were married for 57 years. For the last four, their granddaughter, photographer…
STAT Plus: Vindicated. New J&J CAR-T myeloma data confirm strong efficacy, ease doubts raised by Chinese version
ORLANDO, Fla. — One year ago, a Chinese scientist stepped up to a podium at…
STAT Plus: New data show Bluebird, Bristol CAR-T drug could be pioneering myeloma therapy. Competitors may be close behind
ORLANDO, Fla. — On the eve of a major blood disease research meeting here, Bluebird…
STAT Plus: Lawmakers ask HHS for greater oversight of patient assistance programs
Amid ongoing concern about the use of patient assistance programs by the pharmaceutical industry, two…
Revamped, bipartisan Senate package takes aim at drug prices — and props up other health programs, too
WASHINGTON — Leaders of a key Senate committee unveiled a new version of a sweeping,…
Opinion: Aducanumab: the beginning of the end of Alzheimer’s disease?
In histories written about Alzheimer’s disease, 2019 will turn up as a landmark year, one…
STAT Plus: More hospital drug spending is going toward cancer immunotherapies
Amid intense scrutiny over prescription drug costs, a new analysis finds some hospitals are spending…
Opinion: Cutting 700,000 Americans from SNAP will increase health costs
The Supplemental Nutrition Assistance Program (SNAP) is our nation’s first line of defense against food…
U.S. flu season off to its earliest start in more than 15 years
NEW YORK — The U.S. winter flu season is off to its earliest start in…
Opinion: Creating a Facebook for cell communication can help treat disease
Everyone, it seems, uses Facebook and LinkedIn these days. Social networking sites make it incredibly…
Families are reeling after FDA rejects therapy for kids born without a thymus gland
When Charlie Luckesen turned 2 the Wednesday before Thanksgiving, his family celebrated with a golden…
STAT Plus: Acquisitions, not Congress, will chart biotech’s course in 2020, experts predict
Washington has never before been so focused on lowering prescription drug prices. But these biotech…
Listen: Biogen’s big reveal, hot takes on Alzheimer’s, & the science of one-eyed sheep
How do you know if a “positive” study is positive? And what if clinical trial…
STAT Plus: Veritas, genetics company founded by George Church, suspends U.S. operations
Veritas Genetics, the Boston-based personal genome testing company co-founded by noted Harvard Medical School professor…
STAT Plus: Bribing doctors in India is allegedly a widespread practice
Seeking to juice profits, some Indian drug makers bribe doctors with credit cards, free trips,…
Gates Foundation CEO Susan Desmond-Hellmann to step down
Sue Desmond-Hellmannn is stepping down as CEO of the Bill and Melinda Gates Foundation, the…
Opinion: Step aside, biomarkers. Look to the bank account for early signs of dementia
One crucial missing piece to the devastating puzzle of Alzheimer’s disease and other types of…
STAT Plus: More than 100 small biotech CEOs sound off against Pelosi’s signature drug pricing bill
WASHINGTON — Nearly 150 CEOs of emerging biotech companies are sending a unified, stark message…
Aurinia’s drug to treat autoimmune kidney disease hits its goals in late-stage trial
Aurinia Pharmaceuticals (AUPH) said Wednesday evening that an experimental medicine used to treat patients with…
STAT Plus: What side effects? Problems with medicines may be vastly underreported to the FDA
It’s no secret that the many side effects caused by medicines do not get reported…